News & Trends - Pharmaceuticals
Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health policy is set to transform over the next 10-15 years to better serve consumers and wider stakeholders, including industry.
Prioritising “prevention and healthcare as an investment” are essential in paving the way for Australians to lead “longer, more productive and healthier lives”, according to Zeller.
Reflecting on his extensive international experience, Zeller highlighted the significant challenges and roadblocks that hinder the development of a long-term strategic vision for health policy.
“There are a massive amount of competing priorities, and so everybody has their entrenched positions… It begs the question, what are we solving for?” he questioned.
Zeller emphasised the crucial role of industry in shaping the conversation around local health policy to address the barriers that still exist.
“We sometimes don’t do a good job as an industry of aligning what we want. We have a role in creating data and metrics that can bring sense to the conversation, and we need to add more uniformity and pragmatism to the discussion,” he highlighted.
Drawing on lessons from other countries, including Estonia, Germany, Hungary and the UK, Zeller identified best practices and strategies that Australia could adopt to enhance its health policy framework.
In conclusion, Zeller outlined key short-term actions, including the need for a “well-executed” response to the HTA review from the government and the appetite for “experimentation” that are essential for steering towards the reimagined future of health policy.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics

Landmark study exposes stark differences in ICD battery life and patient risk
A new independent study examining over 35,000 implantable cardioverter-defibrillators (ICDs) has uncovered significant differences in battery longevity across several medtech […]
MoreNews & Trends - Pharmaceuticals

Industry roundtable to shape Australia’s genomics policy
An invitation-only roundtable of key industry leaders and representatives from both federal and state governments is convening today to shape […]
MoreNews & Trends - MedTech & Diagnostics

Pathology indexation reboot leaves essential services behind
After nearly three decades of stagnation, the federal government has reinstated annual indexation for selected Medicare Benefits Schedule (MBS) pathology […]
MoreDigital & Innovation

Navigating telehealth’s crowded rulebook: New consortium adds its voice to the mix
A newly formed Consortium of telehealth providers and private health insurers has come together to develop national standards for the […]
More